Xenetic Biosciences (XBIO) Reports Q2 Loss of $0.34/Share

Xenetic Biosciences (NASDAQ: XBIO) reported Q2 EPS of ($0.34), versus ($6.12) reported last year.

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
• Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)